An American biochemist whose research has helped scientists make inroads on treating coronavirus and HIV has won this year’s ...
A new method is developed to track dormant HIV-infected cells. This breakthrough may lead to new treatments that eliminate ...
Researchers from Imperial College London, working with the University of Oxford and Rockefeller University, have shown ...
Gilead's CROI 2025 data highlights Biktarvy's sustained HIV/HBV suppression, lenacapavir's efficacy, and vesatolimod's safety ...
The U.S. faces an ongoing HIV epidemic, with women, particularly women of color, bearing a heavy burden. While there have ...
3don MSN
A new study led by Western researchers is the first to identify a factor that could influence how fast the pocket where human ...
5d
UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who ...
The combination demonstrated non-inferiority to comparator antiretroviral therapies, meeting the primary efficacy success ...
“Our contributions to CROI spotlight our dedication to scientific discovery, reflect our commitment to addressing the diverse treatment needs and preferences of communities affected by HIV and ...
Such ‘regained’ post-treatment control may be associated with an immune response to the virus. There was also a reduction in CD4+ T cell-associated HIV Gag RNA in some PLWH during treatment ...
Montgomery Advertiser on MSN2d
Alabama still fighting HIV: 'In the South is where we have the majority of the problems':Nearly half of all new cases in 2022 were in the South. "The frustrating part is we have the tools now to stop it." ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback